We established Taiyo Pharma Co., Ltd. (“Taiyo Pharma”) as a wholly owned subsidiary to make the leap to becoming a comprehensive chemical company. Taiyo Holdings Co., Ltd. (Taiyo Holdings) will make a full-scale entrance into the pharmaceuticals business through Taiyo Pharma.
In our medical & pharmaceuticals business, we are focusing mainly on the expansion of prescription drug manufacturing and sale. The mission statement of Taiyo Pharma is “a company that is serious about drugs that are needed.” Our goal is to be a company that provides a stable supply of important drugs that are needed and have an established track record of use over the long-term, while also developing drugs that are needed to meet the needs of patients and those on the frontlines of medical treatment.
Taiyo Holdings entered the pharmaceuticals business full-scale with the acquisition of long-listed products by Taiyo Pharma. In the future we will work to expand the long-listed products business by acquiring more products, and will take on the challenge of developing products that meet the needs of the world. We also intend to maintain a prescription pharmaceuticals manufacturing plant within the Group, utilize the technology and manufacturing expertise we have accumulated in the Taiyo Group, and employ our overseas network to expand our business, with a focus mainly on manufacturing.
Name：TAIYO Pharma Co., Ltd.
Head Office：14F, Marunouchi Kitaguchi Building, 1-6-5 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
Established：August 2, 2017
Name: TAIYO Pharma Tech Co., Ltd.
Head Office: 4-38,Aketacho,Takatsuki,Osaka 569-0806,Japan
Established：April 25, 2019
Capital：300 million JPY